Astrana Health, Inc. (ASTH) stock
ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3022% above fair value
$31.99−0.88 (-2.68%)
Close on Nov 17, 2026Market cap $1.78BP/E 39.0Yield –
Astrana Health pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Astrana Health's pe ratio was 40.2× on Nov 11, 2026, against 115.2× a year earlier. Over the last 5 years it ranged from 21.4× to 124.0×, with a median of 34.7×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 40.2× | −83.9 |
| 2025 | Dec 31, 2025 | 124.0× | +99.8 |
| 2024 | Dec 31, 2024 | 24.3× | −16.1 |
| 2023 | Dec 29, 2023 | 40.3× | +18.1 |
| 2022 | Dec 30, 2022 | 22.2× | −26.7 |
| 2021 | Dec 31, 2021 | 49.0× | +29.3 |
| 2020 | Dec 31, 2020 | 19.6× | −147.7 |
| 2019 | Dec 31, 2019 | 167.4× | – |
See a number that looks wrong?